Revolution Medicines’ buyout price soars after pancreatic cancer win
Revolution Medicines has seen its buyout valuation surge following the successful results of its Phase…
Newswire
TRACERx MRD Results Showcase ppmSeq’s Ultra-Sensitive ctDNA Detection at AACR
At the recent AACR meeting, Ultima Genomics unveiled compelling findings regarding its ppmSeq technology, which…
CVMP Grants Positive Opinion for Nobivac NXT HCPChFeLV Marketing Authorization
The Committee for Veterinary Medicinal Products (CVMP) has adopted a positive opinion for the marketing…
EMA Recommends Authorisation of First Veterinary Vaccine Using RNA Technology
The European Medicines Agency (EMA) has recommended granting marketing authorisation for Nobivac NXT HCPChFeLV, marking…
Kailera Therapeutics Raises $625 Million in Record Biotech IPO
Kailera Therapeutics has achieved a significant milestone in the biotech sector by raising $625 million…
Five Pharma CEOs Join the $30 Million Club with Notable Pay Hikes in 2025
Several of pharma’s top leaders scored large pay bumps last year, including two new chiefs…
FDA’s Accelerated Approval Pathway Needs Stronger Transparency, Evidence Standards: ICER
The FDA must enhance the evidence requirements for drug approvals under its accelerated pathway, while…
Aligos and Xiamen Amoytop Sign Deal for HBV Therapy
Aligos Therapeutics has entered into a strategic partnership with Xiamen Amoytop Biotech to develop and…
Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
The U.S. Court of Appeals has reinstated a $177 million verdict in favor of Teva…
Innovators Overcome Barriers to Advance In Vivo Cell Therapy
As in vivo cell therapies progress into clinical trials, a new wave of innovators is…